إعلان
إعلان
HUMA
Humacyte, Inc. Common Stock
1.17
USDبرعاية
0.00
-0.34%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
1.18
+0.01
+0.77%
تقارير أرباح HUMA
النسبة الإيجابية المفاجئة
HUMA تفوق 12 من 19 آخر التقديرات.
63%
التقرير التالي
بيانات التقرير القادم
٢٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.37M
/-$0.13
التغير الضمني من Q3 25 (Revenue/ EPS)
+81.90%
/+18.18%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-18.75%
Humacyte, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, HUMA reported earnings of -0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.16 USD, resulting in a 31.89% surprise. Revenue reached 753.00 ألف, compared to an expected 940.78 ألف, with a -19.96% difference. The market reacted with a -2.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 المحللين forecast an EPS of -0.13 USD, with revenue projected to reach 1.37 مليون USD, implying an زيادة of 18.18% EPS, and زيادة of 81.90% in Revenue from the last quarter.
الأسئلة الشائعة
What were Humacyte, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Humacyte, Inc. Common Stock reported EPS of -$0.11, beating estimates by 31.89%, and revenue of $753.00K, -19.96% below expectations.
How did the market react to Humacyte, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.34%, changed from $1.28 before the earnings release to $1.25 the day after.
When is Humacyte, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٦ مارس ٢٠٢٦.
What are the forecasts for Humacyte, Inc. Common Stock's next earnings report?
Based on 8
المحللين, Humacyte, Inc. Common Stock is expected to report EPS of -$0.13 and revenue of $1.37M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان